Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Nora Rosas-Murrieta
Differential Transcription of SOCS5 and SOCS7 in Multiple Sclerosis Patients Treated With Interferon Beta or Glatiramer Acetate
International Journal of Molecular Sciences
Organic Chemistry
Molecular Biology
Theoretical Chemistry
Inorganic Chemistry
Computer Science Applications
Spectroscopy
Medicine
Catalysis
Physical
Molecular Diagnostics as an Indispensable Tool for the Diagnosis of Infectious Diseases of Viral Origin and Global Impact
Related publications
T-Cell Interferon Gamma Receptor Binding in Interferon Beta-1b–Treated Patients With Multiple Sclerosis
Archives of Neurology
Cost-Effectiveness of Glatiramer Acetate and Interferon Beta-1a for Relapsing-Remitting Multiple Sclerosis, Based on the Combirx Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Serum S100B in Primary Progressive Multiple Sclerosis Patients Treated With Interferon-Beta-1a
Journal of Negative Results in BioMedicine
Genetics
Pharmacology
Molecular Biology
Biochemistry
Medicine
Toxicology
Pharmaceutics
Assessing the Long-Term Effectiveness of Interferon-Beta and Glatiramer Acetate in Multiple Sclerosis: Final 10-Year Results From the UK Multiple Sclerosis Risk-Sharing Scheme
Journal of Neurology, Neurosurgery and Psychiatry
Psychiatry
Mental Health
Neurology
Surgery
Pnd34 - Payer and Societal Benefit of Peginterferon Beta-1a Versus Glatiramer Acetate in Patients With Relapsing-Remitting Multiple Sclerosis in Spain
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd33 - Payer and Societal Benefit of Peginterferon Beta-1a Versus Glatiramer Acetate in Patients With Relapsing-Remitting Multiple Sclerosis in Italy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Fludarabine Add-On Therapy in Interferon-Beta-Treated Patients With Multiple Sclerosis Experiencing Breakthrough Disease
Therapeutic Advances in Neurological Disorders
Neurology
Pharmacology
Neutralizing Antibodies in Interferon Beta Treated Patients With Multiple Sclerosis: Knowing What to Do Now
Journal of Neurology
Neurology
Glatiramer Acetate in the Reduction of Relapse Frequency in Multiple Sclerosis
Clinical Medicine Insights: Therapeutics
Medicine
Pharmacology
Pharmaceutical Science
